The Scientist - Home

A pill is shown on a blue technical background. One half of the pill has a DNA helix on it, and the other half has a depiction of a computer chip, representing the role of artificial intelligence in drug development.
| 3 min read
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.

Latest

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

Researchers Applaud Call For A `National Science Forum'

The Scientist Placeholder Image

NIH Women's Health Study Takes A Giant Step Forward

The Scientist Placeholder Image

New Leader At AAU Seen Likely To Be Boon For Science

The Scientist Placeholder Image

Dartmouth Receives Funding For Two Projects To Teach Science Ethics

The Scientist Placeholder Image

Fledgling Neuroscience Society Provides Sharper Focus

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

Emeritus Status Offers Some Distinguished Faculty A Chance To Parlay Investigations On Higher Level

The Scientist Placeholder Image

Report Says Biotech Ventures Will Face 'Uncertainty' in ' 93

The Scientist Placeholder Image

As Challenges Mount for Academic Research, More Scientists Take Administrative Positions

The Scientist Placeholder Image

Copyright Decision Should Protect Scientific Publishers

The Scientist Placeholder Image

Notebook

Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies